SC 13G Filing

Company

Oncotelic Therapeutics, Inc.

Filed

July 22, 2009

Accession Number

0000929638-09-001230

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →